By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Raily Aesthetic Medicine International Holdings Limited

Raily Aesthetic Medicine International Holdings Limited (2135.HK)

HKSE Market Data in HKD, Fundamentals in CNY
$0.12
$0.00
+0.85%
Last Update: 29 Aug 2025, 10:16
$66.29M
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.09 - $0.28
52 Week Range

2135.HK Stock Price Chart

Explore Raily Aesthetic Medicine International Holdings Limited interactive price chart. Choose custom timeframes to analyze 2135.HK price movements and trends.

2135.HK Company Profile

Discover essential business fundamentals and corporate details for Raily Aesthetic Medicine International Holdings Limited (2135.HK) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Care Facilities

IPO Date

28 Dec 2020

Employees

290.00

CEO

Jianliang Song

Description

Raily Aesthetic Medicine International Holdings Limited, an investment holding company, provides aesthetic medical services. The company operates through three segments: Aesthetic Medical Services, Consulting Services, and Aesthetic Medical Equipment Products. Its services include aesthetic surgery services, including aesthetic surgical procedures performed on various parts of the face or body; minimally invasive aesthetic services, primarily comprising aesthetic injection procedures; aesthetic dermatology services, such as various aesthetic energy-based procedures; and aesthetic medical management consulting services. The company also offers aesthetic dental services, including orthodontics, and dental implant and whitening; and trades in medical equipment. In addition, it sells surgical implants and aesthetic medical skincare products. The company owns and operates a network of four private for-profit aesthetic medical institutions in Zhejiang and Anhui Province, the People's Republic of China. It serves individual retail clients and aesthetic medical institutions. The company was founded in 2008 and is headquartered in Hangzhou, the People's Republic of China. Raily Aesthetic Medicine International Holdings Limited operates as a subsidiary of Ruide Consultation Limited.

2135.HK Financial Timeline

Browse a chronological timeline of Raily Aesthetic Medicine International Holdings Limited corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 27 Jun 2025

Earnings released on 28 Jun 2024

Stock split effective on 5 Apr 2024

Shares were split 23 : 20 , changing the number of shares outstanding and the price per share accordingly.

Stock split effective on 19 Mar 2024

Shares were split 1 : 5 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 15 Mar 2024

EPS came in at -$0.04 , while revenue for the quarter reached $49.23M .

Earnings released on 31 Dec 2023

EPS came in at -$0.07 , while revenue for the quarter reached $99.41M .

Earnings released on 30 Jun 2023

EPS came in at -$0.01 , while revenue for the quarter reached $110.26M .

Earnings released on 31 Mar 2023

EPS came in at -$0.00 , while revenue for the quarter reached $55.69M .

Earnings released on 31 Dec 2022

EPS came in at -$0.04 , while revenue for the quarter reached $78.69M .

Earnings released on 30 Sept 2022

EPS came in at -$0.02 , while revenue for the quarter reached $38.52M .

Earnings released on 30 Jun 2022

EPS came in at $0.00 , while revenue for the quarter reached $113.88M .

Earnings released on 31 Mar 2022

EPS came in at $0.00 , while revenue for the quarter reached $58.17M .

Earnings released on 31 Dec 2021

EPS came in at -$0.03 , while revenue for the quarter reached $117.14M .

Earnings released on 30 Sept 2021

EPS came in at -$0.02 , while revenue for the quarter reached $58.42M .

Earnings released on 30 Jun 2021

EPS came in at -$0.01 , while revenue for the quarter reached $109.68M .

Earnings released on 31 Mar 2021

EPS came in at -$0.01 , while revenue for the quarter reached $54.17M .

Earnings released on 31 Dec 2020

EPS came in at $0.03 , while revenue for the quarter reached $62.83M .

Earnings released on 30 Sept 2020

EPS came in at $0.03 , while revenue for the quarter reached $60.33M .

2135.HK Stock Performance

Access detailed 2135.HK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run